Phase III long-term study and comparative clinical study of nipradilol ophthalmic solution in patients with primary open-angle glaucoma and ocular hypertension. Part 2

Arzneimittelforschung. 2006;56(12):820-5.
No abstract available

Publication types

  • Clinical Trial, Phase III
  • Comparative Study
  • Randomized Controlled Trial

MeSH terms

  • Adrenergic beta-Antagonists / administration & dosage*
  • Adrenergic beta-Antagonists / therapeutic use*
  • Adult
  • Aged
  • Blood Pressure / drug effects
  • Double-Blind Method
  • Electrocardiography
  • Female
  • Glaucoma, Open-Angle / drug therapy*
  • Heart Rate / drug effects
  • Humans
  • Male
  • Middle Aged
  • Ocular Hypertension / drug therapy*
  • Ophthalmic Solutions
  • Propanolamines / administration & dosage*
  • Propanolamines / therapeutic use*
  • Timolol / administration & dosage
  • Timolol / therapeutic use

Substances

  • Adrenergic beta-Antagonists
  • Ophthalmic Solutions
  • Propanolamines
  • Timolol
  • nipradilol